Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glycosylation profile of <i>Mycobacterium leprae</i>-specific antibodies associated with disseminated infection.

iScience·2026
Same author

Host-derived proteomic biomarkers for discriminating the tuberculosis disease spectrum in a Brazilian cohort.

Tuberculosis (Edinburgh, Scotland)·2026
Same author

The role of hyperbaric oxygen treatment in a case of pyomyositis.

Diving and hyperbaric medicine·2026
Same author

Seroprevalence of <i>Mycobacterium leprae</i> <i>antibodies</i> among school children in Indonesia in 2023: a cross-sectional study.

The Lancet regional health. Southeast Asia·2026
Same author

Exploring generational differences in the impact of stigma on mental health among people affected by leprosy in rural India: a qualitative study.

Scientific reports·2026
Same author

Performance Evaluation of an Automated Neurofilament Light Chain Immunoassay.

The journal of applied laboratory medicine·2026
Same journal

Diplomatic roles of regional coordinators for WHO Member States.

Bulletin of the World Health Organization·2026
Same journal

Evaluation of an application for investments in cataract surgery, Ethiopia.

Bulletin of the World Health Organization·2026
Same journal

An umbrella protocol for the clinical evaluation of diagnostics in infectious disease.

Bulletin of the World Health Organization·2026
Same journal

Fundamental changes in regulation to improve access to biosimilars.

Bulletin of the World Health Organization·2026
Same journal

A public-private partnership for facility-based tuberculosis screening using chest radiographs, Viet Nam.

Bulletin of the World Health Organization·2026
Same journal

Ebola at a critical juncture: preparedness must outpace transmission.

Bulletin of the World Health Organization·2026
See all related articles

Related Experiment Video

Updated: Jun 30, 2026

DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat VNTR - Fragment Length Analysis FLA
09:39

DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat VNTR - Fragment Length Analysis FLA

Published on: July 15, 2011

27.2K

Target product profiles: leprosy diagnostics.

Petra Kukkaro1, Sundeep Chaitanya Vedithi2, David J Blok3

  • 1Novartis Pharma AG, Basel, Switzerland.

Bulletin of the World Health Organization
|April 2, 2024
PubMed
Summary
This summary is machine-generated.

The World Health Organization (WHO) developed diagnostic targets to reduce leprosy cases by 70% by 2030. These profiles focus on accessible, affordable tests for early detection and prevention of leprosy.

More Related Videos

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
10:32

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice

Published on: March 23, 2014

15.0K
Author Spotlight: Leptospira DNA Detection in Water for Environmental Analysis and Disease Surveillance
06:05

Author Spotlight: Leptospira DNA Detection in Water for Environmental Analysis and Disease Surveillance

Published on: June 14, 2024

1.2K

Related Experiment Videos

Last Updated: Jun 30, 2026

DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat VNTR - Fragment Length Analysis FLA
09:39

DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat VNTR - Fragment Length Analysis FLA

Published on: July 15, 2011

27.2K
Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
10:32

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice

Published on: March 23, 2014

15.0K
Author Spotlight: Leptospira DNA Detection in Water for Environmental Analysis and Disease Surveillance
06:05

Author Spotlight: Leptospira DNA Detection in Water for Environmental Analysis and Disease Surveillance

Published on: June 14, 2024

1.2K

Area of Science:

  • Medical Diagnostics
  • Infectious Disease Control
  • Public Health

Background:

  • The World Health Organization (WHO) has a goal to reduce new leprosy cases by 70% by 2030.
  • Advancements in leprosy diagnostics are crucial for achieving this global health target.
  • Current diagnostic methods require improvement for early detection and prevention.

Purpose of the Study:

  • To develop WHO's target product profiles (TPPs) for leprosy diagnostics.
  • To define criteria for diagnostic test design, performance, and distribution.
  • To guide the development of accessible and affordable leprosy diagnostic tools.

Main Methods:

  • Defined criteria for two TPPs: one for symptomatic diagnosis and one for asymptomatic contact screening.
  • Utilized statistical modeling to determine necessary sensitivity and specificity requirements.
  • Considered challenges related to varying endemicity and target analyte performance.

Main Results:

  • Two distinct TPPs were developed, addressing different diagnostic needs in leprosy control.
  • Statistical modeling informed the performance requirements for diagnostic accuracy.
  • Identified challenges in achieving high specificity and robust analyte performance.

Conclusions:

  • Appropriately designed and performing diagnostics are essential for early leprosy detection.
  • The developed TPPs will guide the creation of crucial diagnostic tools.
  • The focus is shifting towards leprosy prevention through improved diagnostics and interventions.